Back to News
Market Impact: 0.3

Sumitomo Chemical Company, Limited - Depositary Receipt (SOMMY) Price Target Decreased by 13.57% to 14.77

NDAQ
Analyst EstimatesAnalyst InsightsInvestor Sentiment & PositioningCompany Fundamentals
Sumitomo Chemical Company, Limited - Depositary Receipt (SOMMY) Price Target Decreased by 13.57% to 14.77

Analysts have revised down the average one-year price target for Sumitomo Chemical Company, Limited (OTCPK:SOMMY) to $14.77 per share, representing a 13.57% decrease from the prior estimate of $17.09. Despite this reduction, the new target still suggests a substantial 43.71% upside from the latest closing price of $10.28. Institutional interest in SOMMY remains negligible, with only one fund reporting positions holding 0K shares, indicating very limited institutional conviction.

Analysis

The average one-year price target for Sumitomo Chemical Company, Limited (OTCPK:SOMMY) has been revised downwards to $14.77 per share. This represents a 13.57% reduction from the prior estimate of $17.09, which was dated September 12, 2025. Despite this downgrade, the new target still implies a significant 43.71% upside from the latest reported closing price of $10.28 per share, with targets ranging from $13.74 to $16.96. Institutional interest in SOMMY remains extremely low, with only one fund reporting positions, unchanged over the last quarter. Total institutional ownership stands at 0K shares, with an average portfolio weight of 0.00%, indicating a lack of significant institutional conviction or active management. This negligible institutional presence has been consistent. The mixed signal of a reduced analyst price target alongside substantial implied upside suggests a re-evaluation of future growth prospects by analysts, potentially due to new information or revised models. However, the persistent absence of meaningful institutional investment could temper enthusiasm for the stock, despite the attractive price target.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo